Long Beach, CA, United States of America

Julie A Buckmeier

This inventor holds 1 USPTO granted patent. Top assignee: Cognis Australia Pty., Ltd.. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Julie A Buckmeier. Retrieved from https://idiyas.com/inventor/julie-a-buckmeier

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Julie A. Buckmeier

Introduction

Julie A. Buckmeier is an accomplished inventor based in Long Beach, California. He has made significant contributions to the field of cancer research through his innovative work. His dedication to developing methods for cancer prevention has led to the creation of a notable patent.

Latest Patents

Julie A. Buckmeier holds a patent for a "Carotenoid agent for inhibiting the conversion of epithelial cells to tumors." This invention discloses a method of inhibiting carcinogen-mediated conversion of melanocyte cells and protecting DNA against carcinogen-mediated damage. The composition comprises a water-insoluble carotenoid, such as beta-carotene, which plays a crucial role in cancer prevention.

Career Highlights

Throughout his career, Buckmeier has been associated with Cognis Australia Pty., Ltd., where he has focused on research and development in the field of health and nutrition. His work has been instrumental in advancing the understanding of how certain compounds can mitigate cancer risks.

Collaborations

Julie has collaborated with notable colleagues, including Lance Elliot Schlipalius and Frank L. Meyskens. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation.

Conclusion

Julie A. Buckmeier's contributions to cancer research through his innovative patent demonstrate his commitment to improving health outcomes. His work continues to inspire advancements in the field of oncology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…